D. Selimoglu-buet, O. Wagner-ballon, V. Saada, V. Bardet, R. Itzykson et al., Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia, Blood, vol.125, issue.23, pp.3618-3626, 2015.
DOI : 10.1182/blood-2015-01-620781

L. Ziegler-heitbrock, P. Ancuta, S. Crowe, M. Dalod, V. Grau et al., Nomenclature of monocytes and dendritic cells in blood, Blood, vol.116, issue.16, pp.74-80, 2010.
DOI : 10.1182/blood-2010-02-258558
URL : https://hal.archives-ouvertes.fr/hal-00611173

C. Talati, L. Zhang, G. Shaheen, A. Kuykendall, M. Ball et al., Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis, Blood, vol.129, issue.13, pp.1881-1883, 2017.
DOI : 10.1182/blood-2016-12-753210

D. Selimoglu-buet, B. Badaoui, E. Benayoun, A. Toma, P. Fenaux et al., Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML, Blood, vol.130, issue.6, pp.832-835, 2017.
DOI : 10.1182/blood-2017-04-779579

M. Patnaik, M. Timm, R. Vallapureddy, T. Lasho, R. Ketterling et al., Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis, Blood Cancer Journal, vol.7, issue.7, p.584, 2017.
DOI : 10.1080/10428194.2016.1243681
URL : https://www.nature.com/articles/bcj201766.pdf

M. Ball, A. List, and E. Padron, When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia, Blood, vol.128, issue.20, pp.2381-2387, 2016.
DOI : 10.1182/blood-2016-07-692988

M. Roussel, C. Benard, B. Ly-sunnaram, and T. Fest, Refining the white blood cell differential: The first flow cytometry routine application, Cytometry Part A, vol.20, issue.6, pp.552-563, 2010.
DOI : 10.1111/j.1600-0609.2008.01052.x
URL : http://onlinelibrary.wiley.com/doi/10.1002/cyto.a.20893/pdf

V. Bardet, O. Wagner-ballon, J. Guy, C. Morvan, C. Debord et al., Groupe d'Etude Immunologique des Leucémies (GEIL) Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms, Groupe Francophone des Myélodysplasies (GFM) Haematologica, vol.100, pp.472-478, 2015.

A. Cottard, O. Wagner-ballon, L. Priol, J. Azzaoui, I. Ly-sunarram et al., Improvement of the leukocyte differential performed by flow cytometry using the Page 9 of 12

, Cytometry: Part B -Clinical Cytometry